课题基金 / 基金详情

Improving outcomes in patients with community-acquired severe sepsis: The role of pre-hospital antibiotics.

Improving outcomes in patients with community-acquired severe sepsis: The role of pre-hospital antibiotics.
改善社区获得性严重脓毒症患者的预后:院前抗生素的作用。
批准号:
nhmrc : 1124532
负责人:
A/Pr Andrew Udy
金额:
$18.02万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Early Career Fellowships
财政年份:
2017
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2017-01-01 至 2020-12-31

项目摘要

项目成果

A/Pr Andrew Udy的其他基金

相似基金

相关文献

中文摘要
翻译
当感染导致器官功能障碍时会发生严重的脓毒症。如果不及早治疗,结果仍然很差。有效治疗这种疾病的首要措施是开始使用广谱抗生素。该奖学金将评估护理人员对疑似社区获得性严重脓毒症患者进行院前抗生素治疗的可行性,有效性和安全性,作为改善这一高度脆弱群体患者结局的一种手段。
英文摘要
Severe sepsis occurs when infection causes organ dysfunction. If not treated early, outcomes remain poor. Foremost in effectively treating this condition is the initiation of broad-spectrum antibiotics. This Fellowship will assess the feasibility, efficacy, and safety of pre-hospital antibiotics administered by paramedics to patients with suspected community-acquired severe-sepsis, as a means to improve patient outcomes in this highly vulnerable group.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
STARRT-AKI: STandard versus Accelerated initiation of Renal Replacement Therapy in Acute Kidney Injury
  • 批准号:
    nhmrc : 1127121
  • 项目类别:
    Project Grants
  • 资助金额:
    $144.22万
  • 财政年份:
    2017
  • 负责人:
    A/Pr Andrew Udy
  • 依托单位:
海外基金